1. Home
  2. ITRM vs PDFS Comparison

ITRM vs PDFS Comparison

Compare ITRM & PDFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • PDFS
  • Stock Information
  • Founded
  • ITRM 2015
  • PDFS 1992
  • Country
  • ITRM Ireland
  • PDFS United States
  • Employees
  • ITRM N/A
  • PDFS N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • PDFS EDP Services
  • Sector
  • ITRM Health Care
  • PDFS Technology
  • Exchange
  • ITRM Nasdaq
  • PDFS Nasdaq
  • Market Cap
  • ITRM 35.6M
  • PDFS 668.1M
  • IPO Year
  • ITRM 2018
  • PDFS N/A
  • Fundamental
  • Price
  • ITRM $1.02
  • PDFS $18.21
  • Analyst Decision
  • ITRM Strong Buy
  • PDFS Strong Buy
  • Analyst Count
  • ITRM 2
  • PDFS 3
  • Target Price
  • ITRM $7.00
  • PDFS $33.33
  • AVG Volume (30 Days)
  • ITRM 536.8K
  • PDFS 205.0K
  • Earning Date
  • ITRM 05-13-2025
  • PDFS 05-08-2025
  • Dividend Yield
  • ITRM N/A
  • PDFS N/A
  • EPS Growth
  • ITRM N/A
  • PDFS 25.00
  • EPS
  • ITRM N/A
  • PDFS 0.10
  • Revenue
  • ITRM N/A
  • PDFS $179,465,000.00
  • Revenue This Year
  • ITRM N/A
  • PDFS $18.10
  • Revenue Next Year
  • ITRM $108.39
  • PDFS $18.98
  • P/E Ratio
  • ITRM N/A
  • PDFS $191.00
  • Revenue Growth
  • ITRM N/A
  • PDFS 8.22
  • 52 Week Low
  • ITRM $0.81
  • PDFS $15.91
  • 52 Week High
  • ITRM $3.02
  • PDFS $39.70
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 44.07
  • PDFS 51.04
  • Support Level
  • ITRM $0.88
  • PDFS $18.60
  • Resistance Level
  • ITRM $1.14
  • PDFS $19.89
  • Average True Range (ATR)
  • ITRM 0.10
  • PDFS 0.79
  • MACD
  • ITRM -0.01
  • PDFS 0.26
  • Stochastic Oscillator
  • ITRM 30.56
  • PDFS 69.62

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About PDFS PDF Solutions Inc.

PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.

Share on Social Networks: